Actinium Pharmaceuticals, Inc (AMEX: ATNM) last traded at $1.10, down 1.79% on the session. The quote above updates while this page is open; the figures below are drawn from Actinium Pharmaceuticals, Inc’s own filings and are restated only when a new one is published.
Actinium Pharmaceuticals, Inc trades on AMEX under the ticker ATNM. Its market capitalisation is $34.59 million.
Valuation measures for Actinium Pharmaceuticals, Inc, derived from the latest quote and its most recent SEC filing.
| Market cap | $34.59M |
|---|---|
| Enterprise value | $7.97M |
| P/E ratio | 3.14 |
| Price / sales | 384.28 |
| Price / book | 1.14 |
| Beta | 0.73 |
Trailing-twelve-month figures tagged in Actinium Pharmaceuticals, Inc's XBRL filings with the SEC.
| Revenue (TTM) | $90.0K |
|---|---|
| Net income (TTM) | $11.31M |
| EPS (TTM) | $0.350 |
| Return on equity | 37.32% |
| Cash | $36.47M |
Range and volume for ATNM over the past 52 weeks.
| 52-week high | $1.81 |
|---|---|
| 52-week low | $0.735 |
| Volume | 142.9K |
| Average volume | 140.1K |
| Previous close | $1.12 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.